Skip to main content
Equibles

Rafferty Asset Management, LLC

Position in ARDX — Ardelyx, Inc.

CIK 1389426 New York, NY
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,051,431
-$1,391,614 QoQ
Shares Held
206,163
-49.5% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 250 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. ARDX ranks #86 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 65,798 $32,683,840
2 REGN
Regeneron Pharmaceuticals, Inc.
 38,534 $24,027,490
3 ALNY
Alnylam Pharmaceuticals, Inc.
 55,332 $16,656,591
4 MRNA
Moderna, Inc.
 111,906 $7,836,777
5 INCY
Incyte Corp
 44,663 $5,062,997
6 APGE
Apogee Therapeutics, Inc.
 33,369 $4,429,067
7 TWST
Twist Bioscience Corp
 40,732 $4,190,508
8 ORKA
Oruka Therapeutics, Inc.
 43,110 $4,102,778

All Filings in ARDX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,051,431 206,163
2026-03-31 $2,443,045 407,854
2025-12-31 $2,274,947 390,214
2025-09-30 $1,734,443 314,781
2025-06-30 $1,409,236 359,499
2025-03-31 $1,931,731 393,428
2024-12-31 $2,711,147 534,743
2024-09-30 $4,095,794 594,455
2024-06-30 $4,762,488 642,711
2024-03-31 $7,703,638 1,055,293
2023-12-31 $8,528,186 1,375,514
2023-09-30 $4,479,407 1,097,894
2023-06-30 $7,075,350 2,087,124
2023-03-31 $7,415,552 1,548,132
2021-06-30 $2,117,510 279,355
2021-03-31 $1,102,839 166,592
2020-12-31 $106,599 16,476
2020-09-30 $297,470 56,661
2020-06-30 $211,129 30,510